This event has already taken place. See you in a future edition.
5th RNAi-Based Therapeutics Summit
36 36 people viewed this event.
Despite the exciting advancements and new investments into the field, the development of new RNAi therapeutics is plagued by difficulties with extra-hepatic delivery and scale-up of manufacturing production.
Time: 8:00 am – 4:00 pm
Venue details: Hilton Boston Back Bay, 40 Dalton Street, Boston, Massachusetts, 02115, United States
Speakers: Frank Slack, Professor, Beth Israel Deaconess Medical Center, Harvard Medical School, Ken Yamada, Assistant Professor, University of Massachusetts Medical School, Jay Kim, Chief Executive Officer, K2B Therapeutics, Marie Lindholm, Senior Vice President, Head of Molecular Design, Silence Therapeutics, and more.
Organizer - Hanson Wade